EGFR TKI Treatment Induces Active Deamination of 5-Methylcytosine and Leads to Acquired T790M Resistant Mutation

被引：0
|
作者：
El Kadi, N. [1 ]
Wang, L. [1 ]
Davis, A. [1 ]
Brown, N. [1 ]
Kalemkerian, G. [1 ]
Hassan, K. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
AICDA; EGFR; NSCLC;
D O I：
10.1016/j.jtho.2017.09.549
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA 11.10
引用
收藏
页码：S1846 / S1847
页数：2
相关论文
共 50 条
  • [1] The T790M mutation is acquired through 5-methylcytosine deamination after EGFR TKI treatment in lung cancer
    El Kadi, Najwa
    Wang, Luo
    Davis, April
    Cooke, Alexander
    Vadnala, Varun
    Korkaya, Hasan
    Kalemkerian, Gregory P.
    Hassan, Khaled A.
    CANCER RESEARCH, 2019, 79 (13)
  • [2] The EGFR T790M Mutation Is Acquired through AICDA-Mediated Deamination of 5-Methylcytosine following TKI Treatment in Lung Cancer
    El Kadi, Najwa
    Wang, Luo
    Davis, April
    Korkaya, Hasan
    Cooke, Alexander
    Vadnala, Varun
    Brown, Noah A.
    Betz, Bryan L.
    Cascalho, Marilia
    Kalemkerian, Gregory P.
    Hassan, Khaled A.
    CANCER RESEARCH, 2018, 78 (24) : 6728 - 6735
  • [3] Amethod of Evaluation False-positive EGFR T790M Mutation Based on Deamining 5-methylcytosine
    Nogami, Shohei
    Yoshioka, Susumu
    Hosokawa, Yuki
    Mochizuki, Miki
    Wakamatsu, Hirotake
    Terasaki, Hiroshi
    Shimadu, Mitsunobu
    BUNSEKI KAGAKU, 2022, 71 (1-2) : 59 - 68
  • [4] The development of EGFR resistant mutation, T790M, in lung adenocarcinoma is acquired through a specific cytosine deamination mechanism
    Hassan, Khaled
    El Kadi, Najwa
    Davis, April
    Kalemkerian, Gregory
    Wang, Luo
    Korkaya, Hasan
    CANCER RESEARCH, 2017, 77
  • [5] Detection of T790M mutation in EGFR gene, an EGFR-TKI resistant mutation, in tumor samples unexposed to EGFR TKIs
    Koba, Hayato
    Kimura, Hideharu
    Nishikawa, Shingo
    Yoneda, Taro
    Sone, Takashi
    Kasahara, Kazuo
    CANCER RESEARCH, 2016, 76
  • [6] T790M MUTATION ASSOCIATED WITH BETTER EFFICACY OF CONTINUOUS EGFR-TKI TREATMENT IN ADVANCED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Ren, Shengxiang
    Li, Wei
    Li, Aiwu
    Chen, Xiaoxia
    Gao, Guanghui
    He, Yayi
    Li, Xuefei
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1084 - S1084
  • [7] Epithelial Mesenchymal Transition in TKI Resistant NSCLC with T790M Mutation
    Iderzorig, Tsatsral
    Chhabra, Gagan
    Puri, Neelu
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S286 - S286
  • [8] GefitinibDevelopment of resistant EGFR T790M mutation: case report
    Reactions Weekly, 2016, 1593 (1) : 91 - 91
  • [9] Machine learning-based radiomics strategy for prediction of acquired EGFR T790M mutation following treatment with EGFR-TKI in NSCLC
    Lu, Jiameng
    Ji, Xiaoqing
    Liu, Xinyi
    Jiang, Yunxiu
    Li, Gang
    Fang, Ping
    Li, Wei
    Zuo, Anli
    Guo, Zihan
    Yang, Shuran
    Ji, Yanbo
    Lu, Degan
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [10] Efficacy of YK-029A, a novel EGFR TKI, in advanced NSCLC patients with acquired T790M mutation
    Wan, Rui
    Chau, Yi Fung
    Zhao, Jun
    Liu, Zhe
    Zhao, Mingfang
    Zhao, Yanqiu
    Dai, Xiumei
    Pan, Yueyin
    Zhang, Zhihong
    Yao, Yu
    Yang, Kunyu
    Wu, Lin
    Xie, Yanyan
    Chen, Bi
    Yang, Yixuan
    Guo, Yongqi
    Wang, Jie
    Duan, Jianchun
    CANCER RESEARCH, 2024, 84 (07)
12345